Chronic leukaemia

• Personal Stories

Coronavirus reports – Part 10: “I didn’t see my mum before I went into surgery”

This Childhood Cancer Awareness Month, we caught up with families who have been affected by children’s and young people’s cancers to find out how COVID-19 has impacted them and their loved ones. This Childhood Cancer Awareness Month, we caught up with families who have been affected by children’s and young people’s cancers to find out how COVID-19 has impacted them and their loved ones.

15 September 2021

• Health & Medicine

Scottish Medicines Consortium says yes to chemotherapy-free leukaemia treatment

The Scottish Medicines Consortium (SMC) has approved a new chemotherapy-free treatment option for some adults with untreated chronic lymphocytic leukaemia. The Scottish Medicines Consortium (SMC) has approved a new chemotherapy-free treatment option for some adults with untreated chronic lymphocytic leukaemia.

8 December 2020

• Health & Medicine

Chemotherapy free treatment for leukaemia given the green light for NHS in England

A new combination of targeted treatments will now be available for some adults with leukaemia on the NHS in England. A new combination of targeted treatments will now be available for some adults with leukaemia on the NHS in England.

13 November 2020

• Health & Medicine

New treatment option for certain leukaemia patients in Scotland

A targeted combination treatment for patients with a specific type of blood cancer will soon be available on the NHS in Scotland. A targeted combination treatment for patients with a specific type of blood cancer will soon be available on the NHS in Scotland.

14 August 2019

• Science & Technology

Drug that targets stem cells could help treat leukaemia

A new drug that can kill specialised stem cells could lead to a new treatment for a type of leukaemia. A new drug that can kill specialised stem cells could lead to a new treatment for a type of leukaemia.

15 September 2016

• Health & Medicine

NICE kicks off 'new approach' with leukaemia drug approval

A drug previously considered too expensive for the NHS will now become widely available after NICE agreed a discount A drug previously considered too expensive for the NHS will now become widely available after NICE agreed a discount

8 July 2016

Bioinvent’s BI-1206 antibody to enter collaborative phase I/II trial funded and conducted by Cancer Research UK, Cancer Research Technology and Leukaemia & Lymphoma Research

Cancer Research UK, Cancer Research Technology and Leukaemia & Lymphoma Research to trial BioInvent's antibody drug for non-Hodgkin lymphoma. Cancer Research UK, Cancer Research Technology and Leukaemia & Lymphoma Research to trial BioInvent's antibody drug for non-Hodgkin lymphoma.

20 January 2015

• Science & Technology

Broken cell 'stopwatch' could lead to blood test to signal how fast leukaemia will progress

Scientists have pinpointed key changes to the telomeres in the cells of leukaemia patients which could play a crucial role in the earliest stages of the disease, according to research published online in the journal Blood. Scientists have pinpointed key changes to the telomeres in the cells of leukaemia patients which could play a crucial role in the earliest stages of the disease, according to research published online in the journal Blood.

10 June 2010